Two Sigma Advisers’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-234,456
| Closed | -$98.5K | – | 2840 |
|
|
2022
Q4 | $98.5K | Sell |
234,456
-285,489
| -55% | -$153K | ﹤0.01% | 2301 |
|
|
2022
Q3 | $406K | Sell |
519,945
-130,911
| -20% | -$138K | ﹤0.01% | 1935 |
|
|
2022
Q2 | $833K | Sell |
650,856
-23,300
| -3% | -$30.7K | ﹤0.01% | 1690 |
|
|
2022
Q1 | $951K | Buy |
674,156
+15,700
| +2% | +$33.6K | ﹤0.01% | 1663 |
|
|
2021
Q4 | $1.79M | Buy |
658,456
+459,000
| +230% | +$1.69M | ﹤0.01% | 1250 |
|
|
2021
Q3 | $949K | Sell |
199,456
-15,200
| -7% | -$111K | ﹤0.01% | 1645 |
|
|
2021
Q2 | $1.73M | Buy |
214,656
+114,700
| +115% | +$955K | ﹤0.01% | 1361 |
|
|
2021
Q1 | $802K | Buy |
99,956
+86,500
| +643% | +$806K | ﹤0.01% | 1776 |
|
|
2020
Q4 | $120K | Sell |
13,456
-32,200
| -71% | -$268K | ﹤0.01% | 2249 |
|
|
2020
Q3 | $343K | Sell |
45,656
-3,800
| -8% | -$26.3K | ﹤0.01% | 1965 |
|
|
2020
Q2 | $315K | Sell |
49,456
-5,500
| -10% | -$36.8K | ﹤0.01% | 2104 |
|
|
2020
Q1 | $408K | Sell |
54,956
-46,500
| -46% | -$360K | ﹤0.01% | 1885 |
|
|
2019
Q4 | $915K | Sell |
101,456
-4,300
| -4% | -$36.1K | ﹤0.01% | 1620 |
|
|
2019
Q3 | $793K | Sell |
105,756
-10,600
| -9% | -$59.5K | ﹤0.01% | 1536 |
|
|
2019
Q2 | $604K | Sell |
116,356
-14,100
| -11% | -$91.9K | ﹤0.01% | 1733 |
|
|
2019
Q1 | $1.09M | Buy |
130,456
+54,300
| +71% | +$391K | ﹤0.01% | 1486 |
|
|
2018
Q4 | $327K | Buy |
+76,156
| New | +$673K | ﹤0.01% | 1949 |
|
|
2018
Q3 | – | Sell |
-13,100
| Closed | -$244K | – | 2449 |
|
|
2018
Q2 | $244K | Buy |
+13,100
| New | +$237K | ﹤0.01% | 2160 |
|
|
2017
Q2 | – | Sell |
-15,200
| Closed | -$181K | – | 2449 |
|
|
2017
Q1 | $181K | Buy |
+15,200
| New | +$182K | ﹤0.01% | 2224 |
|
|
2016
Q3 | – | Sell |
-12,156
| Closed | -$147K | – | 2346 |
|
|
2016
Q2 | $147K | Sell |
12,156
-20,900
| -63% | -$246K | ﹤0.01% | 1924 |
|
|
2016
Q1 | $435K | Buy |
+33,056
| New | +$469K | ﹤0.01% | 1519 |
|
|
2015
Q2 | – | Sell |
-19,856
| Closed | -$385K | – | 2126 |
|
|
2015
Q1 | $385K | Buy |
+19,856
| New | +$344K | ﹤0.01% | 1467 |
|
|
2014
Q3 | – | Sell |
-22,356
| Closed | -$411K | – | 2743 |
|
|
2014
Q2 | $411K | Sell |
22,356
-12,500
| -36% | -$212K | ﹤0.01% | 1806 |
|
|
2014
Q1 | $664K | Sell |
34,856
-18,500
| -35% | -$381K | 0.01% | 1394 |
|
|
2013
Q4 | $1.24M | Buy |
+53,356
| New | +$1.1M | 0.01% | 1021 |
|
Other funds holding IVC
PCMI
IIM
AA
WFA
HNB
HCM
Two Sigma Advisers's IVC Position: Q1 2023 in Review
Two Sigma Advisers sold out of Invacare Corporation (IVC) in Q1 2023, closing a stake of 234,456 shares — an estimated $98.5K sold.
Two Sigma Advisers first reported a position in IVC in Q4 2013 and held it in 25 quarters. The position peaked at $1.79M in Q4 2021. 10 funds tracked by Wall St. Rank hold IVC as of Q1 2023.
- Two Sigma Advisers reported no remaining Invacare Corporation position as of Q1 2023 after selling out during the quarter.
- Two Sigma Advisers sold 234,456 Invacare Corporation shares in Q1 2023, an estimated $98.5K.
- Two Sigma Advisers first reported a position in Invacare Corporation in Q4 2013 and held it in 25 quarters.
- Two Sigma Advisers's Invacare Corporation position peaked at $1.79M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2023.
Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.